The UTEL OTDR can be connected to the input of a UTEL OS-36 to provide test access for multiple fibres. The Optical Test Access Switches can be organised in a cascaded arrangement, which means a single UTEl OTDR can test an entire Optical Distribution Frame(ODF). The OTDR can be controlled remotely using TL1, XML or UTELs bespoke test management software.
Aetna considers pembrolizumab (Keytruda) medically necessary for the following indications: 1  Colorectal cancer - single agent therapy for. Primary treatment for unresectable metachronous metastases and previous adjuvant FOLFOX or CapeOX within the past 12 months; or.
The Keytruda approval is based on clinical trials that showed tumors shrank in 41 percent of patients, and the effect lasted between two and nine months. The most common side effects of Keytruda included fatigue, decreased appetite, shortness of breath or impaired breathing, and cough.